A Possibility to overcome P-glycoprotein (PGP)-mediated multidrug resistance by antibody-targeted drugs conjugated to N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer carrier

N-(2-hydroxypropyl)methacrylamide (HPMA) copolymers containing doxorubicin (DOX) and different targeting moieties were developed with the aim of specific chemotherapy. Two of them, HPMA-conjugated DOX and galactosamine-targeted DOX, are in phase II clinical trials in the U.K. We studied the effect o...

Full description

Saved in:
Bibliographic Details
Published in:European journal of cancer (1990) 1999-03, Vol.35 (3), p.459-466
Main Authors: Št’astný, M., Strohalm, J., Plocová, D., Ulbrich, K., Řı́hová, B.
Format: Article
Language:English
Subjects:
Animals
antibody targeting
Antineoplastic agents
Antineoplastic Agents - administration & dosage
ATP Binding Cassette Transporter, Subfamily B, Member 1 - drug effects
Biological and medical sciences
chemosensitisers
Chemotherapy
Cyclosporine - administration & dosage
doxorubicin
Doxorubicin - administration & dosage
Drug Resistance, Multiple
Drug Resistance, Neoplasm
Drug Screening Assays, Antitumor
HPMA
Humans
Immunotoxins - administration & dosage
Medical sciences
Methacrylates - administration & dosage
Mice
multidrug resistance
P-glycoprotein
Pharmacology. Drug treatments
polymeric prodrugs
Tumor Cells, Cultured
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:N-(2-hydroxypropyl)methacrylamide (HPMA) copolymers containing doxorubicin (DOX) and different targeting moieties were developed with the aim of specific chemotherapy. Two of them, HPMA-conjugated DOX and galactosamine-targeted DOX, are in phase II clinical trials in the U.K. We studied the effect of conjugates with different targeting moieties (anti-CD71, antithymocyte globulin, anti-CD4, transferrin) on human or mouse multidrug resistance (MDR) cell lines (CEM/VLB, P388-MDR). It was shown that targeting decreases the level of MDR for DOX and the level of MDR depends on the targeting moiety used. The combination of these conjugates with chemosensitisers (cyclosporin A, D, G) restored almost completely the sensitivity of MDR cell lines to that of parental sublines. These results suggest that different intracellular trafficking of these conjugates (in membrane-limited organelles) in contrast to free diffusion for low molecular weight compounds might partially overcome P-glycoprotein (Pgp)-mediated MDR. We also report here the development of biodegradable HPMA hydrogels suitable for prolonged release of the cytostatic drug and chemosensitiser as a potential approach to overcome MDR mediated by Pgp.
ISSN:0959-8049
1879-0852
DOI:10.1016/S0959-8049(98)00373-6